journal cover

Airway Remodeling and Hyperreactivity in a Model of Bronchopulmonary Dysplasia and Their Modulation by IL-1 Receptor Antagonist

American Journal of Respiratory Cell and Molecular Biology

Aug 3, 2016

Simon G RoyceClaudia A Nold-Petry

Download from

Publisher
PubMed

Abstract

Bronchopulmonary dysplasia (BPD) is a chronic disease of extreme prematurity that has serious long-term consequences including increased asthma risk. We earlier identified IL-1 receptor antagonist (IL-1Ra) as a potent inhibitor of murine BPD induced by combining perinatal inflammation (...read more

Mentioned in this Paper

Real-Time Polymerase Chain Reaction
Study
Histology Procedure
Pulmonary Alveolar Structure
Entire Lumen of Body System
Lung
Subcutaneous Injections
Interleukin-1
Murine
Alveolar
Paper Details
References
  • References46
  • Citations6
12345
  • References46
  • Citations6
1

Feeds With Similar Papers

Asthma

This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.

American Thoracic Society: Clinical Problems

This feed has been developed in conjunction with the American Thoracic Society for the benefit of its Clinical Problems Assembly. It highlights new and impactful papers on clinical therapeutics, diagnoses, and practices pertaining to respiratory disease.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

American Thoracic Association Journals

Discover the latest respiratory research published by the journals from the American Thoracic Society.

Inotropic Agents & Heart Disease

Inotropic agents alter the force or energy of muscular contractions. Negatively inotropic agents weaken the force of muscular contractions. Positively inotropic agents increase the strength of muscular contraction. Inotropic agents are used in hospitalized patients with acute decompensated heart failure, with reduced left ventricular ejection fraction and with signs of end-organ dysfunction in the setting of a low cardiac output, or with severe systolic heart failure awaiting heart transplant to maintain hemodynamic stability or as a bridge to decision. Discover the latest research on inotrpic agents and heart diseases here.

Childhood Asthma

Childhood asthma is a chronic inflammatory disease that affects the respiratory airways. There are many factors that influence the susceptibility for the development of childhood asthma such as infections, including respiratory syncytial virus and gene-environment interactions. Here is the latest research on childhood asthma.

American Thoracic Society: Allergy, Immunology & Inflammation

This feed has been developed in conjunction with the American Thoracic Society for the benefit of its Allergy, Immunology, and Inflammation Assembly. It highlights new and impactful papers on allergy, asthma, genetics, and the pathogenesis of lung diseases.

Related Papers

Proceedings of the National Academy of Sciences of the United States of America

Interleukin-1 receptor antagonist prevents murine bronchopulmonary dysplasia induced by perinatal inflammation and hyperoxia

Proceedings of the National Academy of Sciences of the United States of AmericaAugust 16, 2013
Marcel F NoldClaudia A Nold-Petry
American Journal of Respiratory Cell and Molecular Biology

Inhibition of β-catenin signaling improves alveolarization and reduces pulmonary hypertension in experimental bronchopulmonary dysplasia

American Journal of Respiratory Cell and Molecular BiologyFebruary 4, 2014
Deepthi AlapatiShu Wu
© 2020 Meta ULC. All rights reserved

Airway Remodeling and Hyperreactivity in a Model of Bronchopulmonary Dysplasia and Their Modulation by IL-1 Receptor Antagonist

American Journal of Respiratory Cell and Molecular Biology

Aug 3, 2016

Simon G RoyceClaudia A Nold-Petry

PMID: 27482635

DOI: 10.1165/rcmb.2016-0031oc

Abstract

Bronchopulmonary dysplasia (BPD) is a chronic disease of extreme prematurity that has serious long-term consequences including increased asthma risk. We earlier identified IL-1 receptor antagonist (IL-1Ra) as a potent inhibitor of murine BPD induced by combining perinatal inflammation (...read more

Mentioned in this Paper

Real-Time Polymerase Chain Reaction
Study
Histology Procedure
Pulmonary Alveolar Structure
Entire Lumen of Body System
Lung
Subcutaneous Injections
Interleukin-1
Murine
Alveolar

Feeds With Similar Papers

Asthma

This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.

American Thoracic Society: Clinical Problems

This feed has been developed in conjunction with the American Thoracic Society for the benefit of its Clinical Problems Assembly. It highlights new and impactful papers on clinical therapeutics, diagnoses, and practices pertaining to respiratory disease.

Related Papers

Proceedings of the National Academy of Sciences of the United States of America

Interleukin-1 receptor antagonist prevents murine bronchopulmonary dysplasia induced by perinatal inflammation and hyperoxia

Proceedings of the National Academy of Sciences of the United States of AmericaAugust 16, 2013
Marcel F NoldClaudia A Nold-Petry
American Journal of Respiratory Cell and Molecular Biology

Inhibition of β-catenin signaling improves alveolarization and reduces pulmonary hypertension in experimental bronchopulmonary dysplasia

American Journal of Respiratory Cell and Molecular BiologyFebruary 4, 2014
Deepthi AlapatiShu Wu
Paper Details
References
  • References46
  • Citations6
12345
  • References46
  • Citations6
1

Download from

Publisher
PubMed
/papers/airway-remodeling-and-hyperreactivity-in-a-model/27482635